Premium
Genetic polymorphism H131R of Fcγ receptor type IIA (FcγRIIA) in a healthy Finnish population and in patients with or without platelet‐associated IgG
Author(s) -
Joutsi Lotta,
Javela Kaija,
Partanen Jukka,
Kekomäki Riitta
Publication year - 1998
Publication title -
european journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0902-4441
DOI - 10.1111/j.1600-0609.1998.tb01082.x
Subject(s) - genotype , platelet , immunology , antibody , medicine , polymorphism (computer science) , fc receptor , antigen , immune thrombocytopenia , population , immune system , monoclonal antibody , receptor , immunofluorescence , gastroenterology , biology , genetics , gene , environmental health
Patients ( n = 113) with histories of thrombocytopenia and with different profiles for platelet‐associated IgG (PA‐IgG) were subdivided according to the genetic polymorphism H131R in the Fcγ receptor type IIA (FcγRIIA). PA‐IgG was measured by the direct platelet immunofluorescence test (PIFT), and GP IIbIIIa and/or GP Ib‐specific PA‐IgG was investigated by a modified version of the direct monoclonal antibody‐specific immobilization of platelet antigens (MAIPA) assay. As a control, the distribution of FcγRIIA polymorphism H131R was determined among 93 healthy Finnish blood donors. The frequencies for H131 and R131 were 0.56 and 0.44 (CI: 0.37–0.51), respectively, which did not differ significantly from those in other Caucasian populations. The distribution of the genotypes HH131, HR131 and RR131 in the patients and controls did not differ significantly. In the HH131 group, the PA‐IgG was higher than in the RR131 group ( p = 0.082). Female patients with the genotype RR131 seemed to be younger than those with HH131 ( p = 0.065). Among the female patients, a significantly greater number were under 40 yr old in the RR131 group than in the HH131 group ( p = 0.0060). Within the RR131 group, the female patients were far younger than the male patients (median 29 vs. 61 yr; p = 0.0021). The results point to the heterogeneity of immune thrombocytopenia, which may partly explain the poor predictive value of PA‐IgG studies.